Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus ...

The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...

The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...

New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...

GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare ...

GSK’s Arexvy receives Japanese regulatory approval for prevention of respiratory syncytial virus disease for older adults: London, UK Tuesday, September 26, 2023, 10:00 Hrs [IST ...

Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease.

In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...

Pregnant people should get an RSV vaccine from Pfizer that transfers antibodies to their babies, according to a new CDC ...

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...

GSK plc (GSK, GSK.L) said Japan's Ministry of Health, Labour and Welfare has approved Arexvy for the prevention of respiratory ...

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60. Arexvy is a vaccine used for the prevention of respiratory syncytial ...